the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Expanded Access Protocol Using I131-MIBG
Official Title An Open Label, Expanded Access Protocol Using 131I-metaiodobenzylguanidine (131I-MIBG)Therapy in Patients With Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma
Principal Investigator Cohn, Susan
Brief Summary Primary Objectives: - Provide palliative therapy with 131I-MIBG for patients with advanced neuroblastoma, pheochromocytoma, or paraganglioma. - Gain more information about acute and late toxicity of 131I-MIBG therapy for patients with refractory neuroblastoma, pheochromocytoma, or paraganglioma.
Gender Both
Ages 12 Months
Enrollment Hello Null!
Accepts Healthy Volunteers
Lead Sponsor Jubilant DraxImage Inc.Industry
Collaborator
Study Design N/A
Study Phase N/A
Study Type Expanded Access
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Neuroblastoma
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI